WO2014106826A3 - Analogue d'anthracycline et utilisations associées - Google Patents
Analogue d'anthracycline et utilisations associées Download PDFInfo
- Publication number
- WO2014106826A3 WO2014106826A3 PCT/IB2014/058075 IB2014058075W WO2014106826A3 WO 2014106826 A3 WO2014106826 A3 WO 2014106826A3 IB 2014058075 W IB2014058075 W IB 2014058075W WO 2014106826 A3 WO2014106826 A3 WO 2014106826A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- relates
- anthracycline analogue
- anthracycline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne un composé purifié de formule 1. L'invention concerne toutes les formes isomères et les formes tautomères du composé de formule 1 et leurs sels et dérivés pharmaceutiquement acceptables. La présente invention concerne en outre les procédés d'isolement et de production du composé de formule 1 par fermentation de la souche PM1029477/MTCC 5709 de Streptomycetes. L'invention concerne également les compositions pharmaceutiques contenant composé de formule 1 sous la forme d'un ingrédient actif et leur utilisation dans le traitement du cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361749788P | 2013-01-07 | 2013-01-07 | |
US61/749,788 | 2013-01-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014106826A2 WO2014106826A2 (fr) | 2014-07-10 |
WO2014106826A3 true WO2014106826A3 (fr) | 2014-10-30 |
Family
ID=51062527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/058075 WO2014106826A2 (fr) | 2013-01-07 | 2014-01-06 | Analogue d'anthracycline et utilisations associées |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014106826A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210935B (zh) * | 2016-12-09 | 2023-08-18 | 凯惠科技发展(上海)有限公司 | 抗体药物偶联物、制备方法、中间体、药物组合物及应用 |
KR20220080139A (ko) * | 2019-10-10 | 2022-06-14 | 셀렉타 바이오사이언시스, 인코퍼레이티드 | 인지질-플라바글린 접합체 및 표적화된 암 치료를 위해 이를 사용하는 방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0022574A1 (fr) * | 1979-07-13 | 1981-01-21 | Sanraku-Ocean Co., Ltd. | Antibiotiques appartenant au groupe rhodomycine et procédé pour leur préparation |
-
2014
- 2014-01-06 WO PCT/IB2014/058075 patent/WO2014106826A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0022574A1 (fr) * | 1979-07-13 | 1981-01-21 | Sanraku-Ocean Co., Ltd. | Antibiotiques appartenant au groupe rhodomycine et procédé pour leur préparation |
Non-Patent Citations (1)
Title |
---|
YOSHIMOTO, A. ET AL.: "Structure-sensitivity relationship of anthracycline antibiotics to C7-reduction by redox enzymes", JAPANESE JOURNAL OF ANTIBIOTICS, vol. 44, no. 3, 1991, pages 287 - 295 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014106826A2 (fr) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
MX2015010971A (es) | Derivado novedoso de pirazol. | |
MX2018015709A (es) | Derivados de azabencimidazol como inhibidores de pi3k beta. | |
PH12014502040A1 (en) | Heterocyclyl compounds | |
NZ631062A (en) | Bromodomain inhibitors | |
IN2014MN02106A (fr) | ||
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
AU2012214029A8 (en) | Rorgammat inhibitors | |
UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
IN2014DN09352A (fr) | ||
GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
WO2014045162A8 (fr) | Composés d'hexahydropyrano[3,4-d][1,3]thiazine-2-amine alkyl-substitués | |
IN2015DN01119A (fr) | ||
PH12016501977A1 (en) | 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES | |
WO2014155300A3 (fr) | Dérivés pyrimidine aminée substitués en tant qu'inhibiteurs de tak-1 | |
MY183974A (en) | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation | |
PH12016500394A1 (en) | Polymorphic form of pyrrole derivative and intermediate thereof | |
CA2878796C (fr) | Derives de pyridinone comme inhibiteurs de la transglutaminase tissulaire | |
CA2920410C (fr) | Derive thienopiperidine et son utilisation | |
IN2014DN00090A (fr) | ||
EA201790016A1 (ru) | АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K | |
MX2021003739A (es) | Derivados de quinolino-pirrolidin-2-ona como inhibidores del gen mutado de ataxia telangiectasia (atm) y el uso de los mismos en el tratamiento de tumores sólidos. | |
MX2017013099A (es) | Metodos para el tratamiento de trastornos inflamatorios. | |
IN2014MN02433A (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14735416 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14735416 Country of ref document: EP Kind code of ref document: A2 |